Cardio-Oncology Community’s Role in Amyloidosis Research and GC-OS Champion’s League expectations – IC-OS
International Cardio-Oncology Society shared a post on LinkedIn: “As part of our session preview series for GCOS26, Abdelrahman Ali sat down with IC-OS Founding Director Daniel Lenihan to discuss how…
Read the full articleYou might also wanna read
ASCO 2026: New hope in AL amyloidosis, with Dr Hans Lee
ASCO 2026: New hope in AL amyloidosis, with Dr Hans Lee Jonah.Comstock Wed, 08/07/2026 - 19:48
Medscape and IMF Partnership: Panel Discussion on CD38-Targeted Therapy for Multiple Myeloma
From tailored quadruplet regimens to innovative delivery systems, discover the patient-centric future of multiple myeloma treatment.
mdsc.pe·1d ago
Patient and Public Involvement opportunities in ME/CFS and other research
Sorry this isn’t very detailed but saw this on bluesky and thought worth sharing. Should I share in the Australia thread too/instead? Thanks
s4me.info·20h ago
FSC chief vows swift plan to ease network separation rules
Financial Services Commission Chairman Lee Eok-won said Friday that authorities will move quickly to draw up plans to fully lift network sep
AI-based OCT analysis reveals plaque composition changes after intensive lipid-lowering therapy in non-obstructive coronary lesions: YELLOW III sub-study
Non-obstructive coronary plaques are a major source of future coronary events, particularly when characterized by high lipid burden and adve
Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer
Conditions : Pancreatic Ductal Adenocarcinoma (PDAC) Sponsors : Beijing Daxiang Biotech Co., Ltd; Ruijin Hospital; Beijing Friendship Hospit
Comments
Sign in to join the conversation.
No comments yet. Be the first.